Akebia Therapeutics Inc (NASDAQ:AKBA)

8.31
Delayed Data
As of Apr 17
 -0.36 / -4.15%
Today’s Change
8.11
Today|||52-Week Range
31.00
-28.61%
Year-to-Date

Today’s Trading

Previous close8.67
Today’s open8.24
Day’s range8.11 - 8.54
Volume5,618,030
Average volume (3 months)212,091
Market cap$169.3M
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)-513.74%
Earnings growth (this year)+101.75%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.63

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp+0.05+0.19%
SYNSynthetic Biologics ...-0.08-3.28%
PVCTProvectus Biopharmac...+0.04+4.65%
ARGSArgos Therapeutics I...-0.31-3.56%
Data as of 4:00pm ET, 04/17/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$0.00
Annual profit (last year)-$37.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John P. Butler
CFO, Treasurer, SVP &
Head-Investor Relations
Jason A. Amello
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers